Astrazeneca reported 28.89B in Loan Capital for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
AstraZeneca AZN:LN 28888M 51M
Canopy Growth Corp WEED:CN C$ 1.6B 81.19M
Corcept Therapeutics CORT:US $ 0M 0M
Genmab GEN:DC 356M 7M
Novartis NOVN:VX SF 24523M 192M
Valeant Pharmaceuticals VRX:CN $ 22654M 296M
Zoetis ZTS:US $ 6592M 0M